The Middle East situation remains volatile, but the market's reaction has become more muted, prompting investors to shift focus toward technology stocks.
BlockBeats news, on June 29, the United States once again struck Iranian military targets over the weekend. In response, Iran attacked ships near the Strait of Hormuz and launched missiles and drones toward Kuwait and Bahrain, which temporarily led to a suspension of ceasefire negotiations between the US and Iran. However, both parties later agreed to pause hostile actions again and continue advancing technical negotiations related to the ceasefire memorandum (MOU).
Due to the current situation, international oil prices rose slightly. Brent crude oil and WTI crude oil rose to approximately $72.31 and $69.82 respectively, but the overall reaction from global financial markets was limited, and investors' attention gradually shifted to the recovery of the technology sector.
AI computing power demand is driving a continued shortage of memory chips. Large technology companies such as Apple and Microsoft can absorb costs through price increases, while some small and medium enterprises face greater pressure. Meanwhile, SpaceX is expected to become one of the fastest companies in history to be included in the Nasdaq 100 Index.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race
Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.
Bernstein Downgrades Nvidia Rating and Target Price

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity
Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

